lewista's heteroresistance [12 articles] Export

Recent papers added to lewista's library classified by the tag heteroresistance. You can also see everyone's heteroresistance.

Hide details

	Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections [My Copy] Annals of Clinical Microbiology and Antimicrobials, Vol. 6 (30 October 2007), 13. by Hui-Min Neoh, Satoshi Hori, Mitsutaka Komatsu, et al.Toyoko Oguri, Fumihiko Takeuchi, Longzhu Cui, Keiichi Hiramatsu posted to glycopeptide heteroresistance mrsa by lewista on 2008-12-05 16:47:06 as
	Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia. [My Copy] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 38, No. 9. (1 May 2004), pp. 1328-1330. by A. Khosrovaneh, K. Riederer, S. Saeed, et al.M. S. Tabriz, A. R. Shah, M. M. Hanna, M. Sharma, L. B. Johnson, M. G. Fakih, R. Khatib posted to heteroresistance mrsa by lewista on 2008-12-02 14:59:51 as
	Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. [My Copy] Antimicrobial agents and chemotherapy, Vol. 50, No. 9. (September 2006), pp. 3039-3047. by B. P. Howden, P. D. Johnson, P. B. Ward, T. P. Stinear, J. K. Davies posted to glycopeptide heteroresistance mrsa by lewista on 2008-12-01 17:03:50 as along with 1 person gwenknight
	A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA) [My Copy] Annals of Clinical Microbiology and Antimicrobials, Vol. 6 (24 September 2007), 9. by Andreas Voss, Johan W. Mouton, Erika, et al.Ron G. Hendrix, Wil Goessens, Jan A. Kluytmans, Paul F. Krabbe, Han, Jacobus H. Sloos, Nefise Oztoprak, Robin A. Howe, Timothy R. Walsh posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-17 08:21:58 as
	Unstable vancomycin heteroresistance is common among clinical isolates of methiciliin-resistant Staphylococcus aureus. [My Copy] Journal of clinical microbiology, Vol. 43, No. 5. (May 2005), pp. 2494-2496. by N. Plipat, G. Livni, H. Bertram, R. B. Thomson posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-17 08:20:49 as
	Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). [My Copy] Journal of clinical microbiology, Vol. 46, No. 9. (September 2008), pp. 2950-2954. by M. J. Rybak, S. N. Leonard, K. L. Rossi, C. M. Cheung, H. S. Sadar, R. N. Jones posted to glycopeptide heteroresistance mrsa mssa by lewista on 2008-11-17 08:18:29 as
	Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. [My Copy] Emerging infectious diseases, Vol. 10, No. 5. (May 2004), pp. 855-857. by R. A. Howe, A. Monk, M. Wootton, T. R. Walsh, M. C. Enright posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-14 16:30:18 as
	A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. [My Copy] Journal of clinical microbiology, Vol. 45, No. 2. (February 2007), pp. 329-332. by M. Wootton, A. P. MacGowan, T. R. Walsh, R. A. Howe posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-14 16:25:54 as
	Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. [My Copy] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 38, No. 4. (15 February 2004), pp. 521-528. by B. P. Howden, P. B. Ward, P. G. Charles, et al.T. M. Korman, A. Fuller, P. du Cros, E. A. Grabsch, S. A. Roberts, J. Robson, K. Read, N. Bak, J. Hurley, P. D. Johnson, A. J. Morris, B. C. Mayall, M. L. Grayson posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-14 15:52:00 as
	Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. [My Copy] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 38, No. 3. (1 February 2004), pp. 448-451. by P. G. Charles, P. B. Ward, P. D. Johnson, B. P. Howden, M. L. Grayson posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-14 15:42:41 as
	Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. [My Copy] The Journal of antimicrobial chemotherapy, Vol. 40, No. 1. (July 1997), pp. 135-136. by K. Hiramatsu, H. Hanaki, T. Ino, K. Yabuta, T. Oguri, F. C. Tenover posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-10 13:00:40 as
	Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. [My Copy] The Journal of antimicrobial chemotherapy, Vol. 42, No. 2. (August 1998), pp. 199-209. by H. Hanaki, K. Kuwahara-Arai, S. Boyle-Vavra, R. S. Daum, H. Labischinski, K. Hiramatsu posted to glycopeptide heteroresistance mrsa by lewista on 2008-11-10 12:56:50 as

Note: You may cite this page as: http://www.citeulike.org/user/lewista/tag/heteroresistance

mrsa	51
glycopeptide	28
mssa	21
genomics	20
environment	17
epidemiology	12
heteroresistance	12
acinetobacter	9
pharmacokinetics	6
diagnostics	5
anthrax	4
crbsi	4
hcai	4
pji	4
prevention	4
tuberculosis	4
endocarditis	3
evolution	3
military	3
pcp	3
rifampicin	3
anaerobes	2
osteomyelitis	2
transplantation	2
aminoglycoside	1
beta-lactamase	1
cap	1
cdiff	1
cns	1
ecoli	1
fungal	1
influenza	1
lyme	1
norovirus	1
pneumonia	1
prophylaxis	1
quality	1
quorum	1
salmonella	1
sepsis	1
snp	1
stewardship	1
tdm	1
typing	1
yersinia	1

lewista's heteroresistance [12 articles] Export

lewista's tags